Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

NIH launches the Home Test to Treat program to provide free COVID-19 health services in selected communities

The National Institutes of Health, in collaboration with the Administration for Strategic Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services, has launched the Home Test to Treat program, an entirely virtual community health intervention that will provide free COVID-19 health services—at-home rapid tests, telehealth sessions and at-home treatments—in selected communities.

5 Jan 2023

Scientists pinpoint the routes taken by SARS-CoV-2 to enter and exit cells in our nasal cavity

Somebody just coughed on you. On a plane. At a dinner party. In a supermarket line. If only there were a "morning after" nasal spray that could knock out respiratory viruses' ability to colonize your nose and throat.

5 Jan 2023

New machine learning tool can shed light on chronic COVID symptoms

Long COVID has emerged as a pandemic within the pandemic. As scientists work to untangle the many remaining unanswered questions about how the initial infection impacts the body, they must now also investigate why some people develop debilitating, chronic symptoms that last months to years longer.

5 Jan 2023

New approach could reduce the computation time for simulating the spread of diseases

Simulations that help determine how a large-scale pandemic will spread can take weeks or even months to run.

5 Jan 2023

Does bimodal visual-olfactory training with patient-preferred scents improve olfaction in individuals with COVID-19 postviral olfactory loss?

Researchers investigated whether using patient-preferred scents and a bimodal method of visual-olfactory training is more effective than unimodal olfactory training using scents assigned by physicians in treating patients experiencing anosmia after COVID-19.

5 Jan 2023

What was the effect of the COVID-19 pandemic on the mental well-being of university students?

Researchers evaluated changes in the mental health status of university-attending students in France 15.0 months post-commencement of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic.

5 Jan 2023

Oxford's Ebola vaccine candidate manufactured and shipped to Uganda in just 80 days

Oxford's Ebola vaccine candidate has been shipped to Uganda, just 80 days after WHO declared a Sudan ebolavirus outbreak, having been manufactured by its partner the Serum Institute of India and working in close partnership with WHO.

5 Jan 2023

Seroprevalence study demonstrates vaccination could boost impaired humoral immunity against Omicron BQ.1.1 subvariant

Researchers conducted a multicenter, cross-sectional seroprevalence study in emergency departments of five hospitals in North Rhine-Westphalia, Germany, between August and September 2022. They assessed point seroprevalence and neutralization activity against Wu01, BA.4/5, and BQ.1.1.

5 Jan 2023

Is platelet-rich plasma therapy beneficial in treating chronic respiratory disease?

Researchers conducted a literature review to determine whether platelet-rich plasma therapy could help slow disease progression through lung regeneration in patients with chronic respiratory disease.

4 Jan 2023

Public health agencies try to restore trust as they fight misinformation

By the summer of 2021, Phil Maytubby, deputy CEO of the health department here, was concerned to see the numbers of people getting vaccinated against covid-19 slipping after an initially robust response.

4 Jan 2023

Working mothers shouldered more of the parenting burden during the pandemic, study finds

A first-of-its-kind study of parents' work arrangements during the pandemic shows that mothers working from home increased their supervisory parenting fully two hours more than fathers did, and women were also more likely to adapt their work schedules to new parenting demands.

3 Jan 2023

Study compares effectiveness of Pfizer vs. Moderna booster COVID vaccines after third dose

In a recent scientific paper published in the journal Nature Microbiology, researchers reproduced two target trials using electronic health records (EHRs) of the Department of Veterans Affairs (VA) to compare the effectiveness of the third dose of BNT162b2 or messenger ribonucleic acid (mRNA)-1273 vaccine among United States (US) veterans.

3 Jan 2023

Major update of the INCOG guidelines for cognitive rehabilitation following traumatic brain injury

A rapidly growing body of evidence shows the importance and effectiveness of cognitive rehabilitation for individuals with traumatic brain injury (TBI).

3 Jan 2023

COVID-19 vaccine safe for children who have had MIS-C

A study of children and adolescents who received a COVID-19 vaccination following multisystem inflammatory syndrome (MIS-C) found that there were no reports of serious complications including myocarditis or MIS-C reoccurrence.

3 Jan 2023

Scientists collaborate to monitor SARS-CoV-2 RNA among domestic and free-ranging animal species

Researchers collaborated with community partners to monitor SARS-CoV-2 infections among domestic and free-ranging animals with known susceptibility to the virus and proximity to humans in Ohio, United States.

3 Jan 2023

Viral short RNAs detected in SARS-CoV-2 RNA transcriptome

Researchers analyzed the ribonucleic acid (RNA) transcriptome associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and SARS-CoV-1-infected human cells.

3 Jan 2023

Phase III trial shows noninferiority of VV116 compared to nirmatrelvir–ritonavir among adults with mild-to-moderate COVID-19 at risk of progression

Researchers presented the results of a phase III randomized controlled trial of oral SARS-CoV-2 antiviral VV116.

3 Jan 2023

Weighing risks of a major surgery: 7 questions older Americans should ask their surgeon

Larry McMahon, who turns 80 this month, is weighing whether to undergo a major surgery. Over the past five years, his back pain has intensified. Physical therapy, muscle relaxants, and injections aren't offering relief.

3 Jan 2023

Underlying genetic cause for MIS-C complications after COVID-19 identified

A recent Science journal study determined the underlying cause of MIS-C related to SARS-CoV-2 in some children. It hypothesized that monogenic inborn errors of immunity (IEI) is the primary reason for this condition. Identifying these inborn errors is expected to help elucidate the disease's cellular, molecular, and immunological basis.

2 Jan 2023

COVID-19 prevention and control measures associated with decrease in influenza activity

A recent study provides preliminary evidence of the long-term relationship between prevention and control measures and influenza transmission in China during the COVID-19 pandemic, accounting for the impact under various prevention and control levels. This study, the first of its kind, was published in Health Data Science, a Science Partner Journal.

2 Jan 2023

Pandemic News and Research

Further Reading

NIH launches the Home Test to Treat program to provide free COVID-19 health services in selected communities

Scientists pinpoint the routes taken by SARS-CoV-2 to enter and exit cells in our nasal cavity

New machine learning tool can shed light on chronic COVID symptoms

New approach could reduce the computation time for simulating the spread of diseases

Does bimodal visual-olfactory training with patient-preferred scents improve olfaction in individuals with COVID-19 postviral olfactory loss?

What was the effect of the COVID-19 pandemic on the mental well-being of university students?

Oxford's Ebola vaccine candidate manufactured and shipped to Uganda in just 80 days

Seroprevalence study demonstrates vaccination could boost impaired humoral immunity against Omicron BQ.1.1 subvariant

Is platelet-rich plasma therapy beneficial in treating chronic respiratory disease?

Public health agencies try to restore trust as they fight misinformation

Working mothers shouldered more of the parenting burden during the pandemic, study finds

Study compares effectiveness of Pfizer vs. Moderna booster COVID vaccines after third dose

Major update of the INCOG guidelines for cognitive rehabilitation following traumatic brain injury

COVID-19 vaccine safe for children who have had MIS-C

Scientists collaborate to monitor SARS-CoV-2 RNA among domestic and free-ranging animal species

Viral short RNAs detected in SARS-CoV-2 RNA transcriptome

Phase III trial shows noninferiority of VV116 compared to nirmatrelvir–ritonavir among adults with mild-to-moderate COVID-19 at risk of progression

Weighing risks of a major surgery: 7 questions older Americans should ask their surgeon

Underlying genetic cause for MIS-C complications after COVID-19 identified

COVID-19 prevention and control measures associated with decrease in influenza activity

Best practices - optimize qPCR processes for pathogen detection eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News